Program
2nd International Congress on
Exacerbations of Airway Disease
(ICEAD2)
Cabos San Lucas, Mexico
November 13 - 15, 2009
Draft Program
Day One, November 13, 2009
11:00 AM Registration Opens
Session I: Asthma Exacerbations in Childhood
| 2:00 - 2:45 PM |
Epidemiology of Asthma Exacerbations in Childhood Rob Lemanske, University of Wisconsin, Madison, Wisconsin, USA |
| 2:45 - 3:15 PM |
New Viruses and Asthma Exacerbations in Childhood James Gern, University of Wisconsin, Madison, Wisconsin, USA |
| 3:15 - 3:45 PM |
Interactions between Viruses and Atopy in Asthma Exacerbations in Childhood Peter Sly, Telethon Institute for Child Health Research, Perth, Australia |
Session II Pathogenesis of Asthma Exacerbations I
| 3:45 - 4:15 PM |
Genetic Risk Factors in Asthma Exacerbations in Childhood Fernando Martinez, Arizona Respiratory Center, University of Arizona, Tucson, USA |
| 4:15 - 4:45 PM |
Coffee Break |
| 4:45 - 5:15 PM |
Acute Severe Asthma Exacerbations in Children - Role of Viruses and Genetics Peter LeSouef, University of Western Australia, Crawley, WA, Australia |
| 5:15 - 5:45 PM |
Mechanisms of Asthma Exacerbations Sebastian Johnston, Imperial College London, UK |
| 5:45 - 6:15 PM |
Role of Viral Infections in Airway Remodeling Nikos Papadopoulos, University of Athens, Greece |
6:15 - 6:45 PM |
Oral Presentations X2 |
| 7:00 - 9:00 PM |
Welcome Reception and Dinner |
Day Two, November 14, 2009
| 7:00 - 8:00 AM | Breakfast |
Session III Treatment/Prevention of Asthma Exacerbation in Childhood
8:00 - 8:30 AM |
Role of Steroids in Prevention of Asthma Exacerbations to be determined |
| 8:30 - 9:00 AM |
Role of Leukotriene Antagonists in Treatment/Prevention of Asthma Exacerbations To be determined |
| 9:00 - 9:30 AM |
Role of Steroids in Treatment of Asthma Exacerbations Jonathan Grigg, Royal London Hospital, London, UK |
| 9:30 - 10:00 AM |
Future needs in Treatment/Prevention of Asthma Exacerbations in Childhood John Price, Kings College, London, UK Invited |
| 10:00 - 10:30 AM |
Coffee Break |
10:30 - 11:00 AM |
Oral Presentations X2 |
Session IV Asthma Exacerbation Pathogenesis II
| 11:00 - 11:30 PM |
Exacerbation Prone Asthma - Characteristics of the Phenotype and Possible Susceptibility Factors John Fahy, University of California, San Francisco, California, USA |
| 11:30 - 12:00 PM |
The August Epidemic of Asthma Exacerbations
Thomas Pulimood, West Suffolk Hospital NHS Trust, Suffolk, United Kingdom |
| 12:00 - 12:30 PM |
Role of Neutrophils in Asthma Exacerbations Peter Gibson, University of Newcastle, Callaghan, New South Wales, Australia |
| 12:30 - 3:00 PM |
Mid Day Break |
| 3:00 - 3:30 PM |
Role of Eosinophils in Asthma Exacerbations William Busse, University of Wisconsin, Madison, Wisconsin, USA |
| 3:30 - 4:00 PM |
Role of Mast Cells in Asthma Exacerbations Peter Bradding, Institute for Lung Health, Leicester, United Kingdom |
| 4:00 - 4:30 PM |
Molecular Mechanisms of Asthma Exacerbations David Proud, University of Calgary, Alberta, Canada |
Session V Treatment of Asthma & COPD Exacerbations
| 4:30 - 5:00 PM |
Monitoring Disease in Prevention of Asthma & COPD Exacerbations Ian Pavord, Institute for Lung Health, Leicester, United Kingdom Invited |
| 5:00 - 5:30 PM |
Coffee Break |
| 5:30 - 6:00 PM |
New Approaches to Treatment/Prevention Anthony Coyle, MedImmune, Gaithersberg, USA |
| 6:00 - 6:30 PM |
Anti-Viral Approaches in Exacerbations Jonathan Sadeh, Schering Plough Research Institute, Kenilworth, New Jersey, USA |
| 6:30 - 7:00 PM |
Combination Therapies for Treatment/Prevention of Exacerbations Paul O'Byrne, Hamilton, Ontario |
| 7:00 - 7:30 PM |
Oral Presentations X2 |
| 7:30 - 8:30 PM |
Wine/Cheese Reception Poster Session |
Day Three, November 15, 2009
7:00 - 8:00 AM Breakfast
Session VI Pathogenesis of COPD Exacerbations
| 8:00 - 8:30 AM |
Role of Oxidative Stress in COPD Exacerbations William MacNee, University of Edinburgh, United Kingdom Invited |
| 8:30 - 9:00 AM |
Bacterial & Viral Infections in COPD Exacerbations Sanjay Sethi, University at Buffalo, SUNY, Buffalo, New York, USA |
| 9:00 - 9:30 AM |
Role of Smoking Cessation in COPD Exacerbations Steve Rennard, University of Nebraska Medical Center, Omaha, Nebraska, , USA |
| 9:30 - 10:00 AM |
An Experimental Model of COPD Exacerbation Patrick Mallia, Imperial College London, United Kingdom Invited |
10:00 - 10:30 AM |
Oral Presentations X2 |
| 10:30 - 11:00 AM |
Coffee Break |
Session VII Treatment/Prevention of COPD Exacerbations
| 11:00 - 11:30 PM |
Role of Macrolides Wisia Wedzicha, University College London and Royal Free Hospital, London, United Kingdon |
| 11:30 - 12:00 PM |
Role of Steroids in COPD Exacerbations Peter Barnes, National Heart and Lung Institute, London, United Kingdom |
| 12:00 - 12:30 PM |
Role of Long Acting Bronchodilators in COPD Exacerbations To be determined |
| 12:30 - 1:00 PM |
Impact of Exacerbations on COPD To be determined |
| 1:00 - 1:30 PM |
Oral Presentations X2 |
| 1:30 - 2:00 PM |
Future Directions & Summary Homer Boushey, University of California, San Francisco, USA |
